Information Hub
Access guidance, webcasts and publications with commentaries using the ABS Information Hub. Search by classification or using keywords.
To view the webcasts from previous ABS Conferences, events and webinars you must be an ABS member and be logged in using your membership username and password.
-
list
Together with the UK Breast Cancer Group, the Association of Breast Pathology and the British Society of Breast Radiology, the ABS have produced a guidance document for Neoadjuvant Chemotherapy (NAC)....
Association of Breast Pathology, ABS, British Society of Breast Radiology & UK Breast Cancer Group, UK | United Kingdom
23.01.2023 | Added: 23.01.2023
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy/ NACT
listGuideline list -
desktop_windows
Radiotherapy and oncoplastic surgery
Mr Ashutosh Kothari | ABS Conference 2024
14.05.2024 | Added: 29.07.2024
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Radiotherapy Oncoplastic Surgery
desktop_windowsWebcast desktop_windows -
desktop_windows
Revision surgery post radiotherapy (1)
Professor J Michael Dixon OBE | ABS Conference 2024
14.05.2024 | Added: 29.07.2024
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Radiotherapy
desktop_windowsWebcast desktop_windows -
desktop_windows
Scar therapy, pre and after radiotherapy
Mrs Emma Holly | ABS Conference 2024
14.05.2024 | Added: 29.07.2024
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Radiotherapy Scars
desktop_windowsWebcast desktop_windows -
desktop_windows
Primum Non Nocere: Abemaciclib
Dr Daniel Ahari | ABS Conference 2024
14.05.2024 | Added: 29.07.2024
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Targeted therapy
desktop_windowsWebcast desktop_windows -
desktop_windows
CDK4 and other advances in hormone positive cancers
Professor Richard Simcock | ABS Conference 2024
14.05.2024 | Added: 29.07.2024
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Endocrine therapy
desktop_windowsWebcast desktop_windows -
desktop_windows
PARP inhibitors in breast surgery
Mr Tim Crook | ABS Conference 2024
14.05.2024 | Added: 29.07.2024
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Targeted therapy
desktop_windowsWebcast desktop_windows -
desktop_windows
Professor Stuart McIntosh | ABS Conference 2024
13.05.2024 | Added: 29.07.2024
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy Trials
desktop_windowsWebcast desktop_windows -
desktop_windows
Improving selection of NAC for young breast cancer patients - study proposal
Ashrafun Nessa | ABS Conference 2024
13.05.2024 | Added: 29.07.2024
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy Management of the Younger Patient
desktop_windowsWebcast desktop_windows -
desktop_windows
The impact of BMI on response to NACT in breast cancer
Richa Jaiswil | ABS Conference 2024
13.05.2024 | Added: 29.07.2024
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy
desktop_windowsWebcast desktop_windows -
list
Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer
In May 2024, NICE published a partial review of previous guidance on tumour profiling tests for guiding adjuvant chemotherapy decisions in early breast cancer. The pre-existing guidance made recommend...
NICE | United Kingdom
01.05.2024 | Added: 01.08.2024
Classifications: Adjuvant & Neoadjuvant Treatment
listGuideline list -
desktop_windows
ENGAGE study: Breast Cancer Chemoprevention
Dr Samuel Smith | ABS Multidisciplinary Meeting 2019
14.01.2024 | Added: 14.01.2019
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Chemoprevention Trials
desktop_windowsWebcast desktop_windows -
desktop_windows
Upfront Oncotype DX in early breast cancer management
Dr Raouef Ahmed Bichoo | ABS Conference 2023
15.05.2023 | Added: 15.05.2023
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Early Breast Cancer Gene Expression Profiling
desktop_windowsWebcast desktop_windows -
desktop_windows
The value of progesterone receptor expression in predicting PCR following NACT
Miss Emily King | ABS Conference 2023
15.05.2023 | Added: 15.05.2023
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy/ NACT
desktop_windowsWebcast desktop_windows -
desktop_windows
Surgery after neo-adjuvant chemotherapy why are breast conservation rates not higher?
Dr Hiram S. Cody III | ABS Conference 2023
15.05.2023 | Added: 15.05.2023
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy/ NACT
desktop_windowsWebcast desktop_windows -
menu_book
MonarchE is an open-label, randomised, phase 3 trial which recruited high risk hormone receptor positive, HER2 receptor negative, node-positive breast cancer patients (n=5637). Patients were randomise...
Prof Stephen R D Johnston, MD et al | The Lancet Oncology
06.12.2022 | Added: 06.12.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Adjuvant treatment Endocrine therapy Trials
menu_bookPublication menu_book -
menu_book
This prospective multicentre cohort study aimed to determine surgical decision-making in the breast and axilla, as well as pathological complete response (pCR) rate in patients undergoing neoadjuvant ...
Hiba Fatayer et al | British Journal of Surgery
09.09.2022 | Added: 09.09.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy/ NACT Early Breast Cancer Trials
menu_bookPublication menu_book -
desktop_windows
Introduction to the ABS, BSBR & UKBCG Guidance on Neoadjuvant Chemotherapy
n/a | Webinar
06.09.2022 | Added: 06.09.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy/ NACT
desktop_windowsWebcast desktop_windows
